Universal Ibogaine Inc. (TSXV:IBO)
0.0050
-0.0050 (-50.00%)
Feb 2, 2026, 9:30 AM EST
Universal Ibogaine Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Mar '21 Mar 31, 2021 |
| 2.06 | 2.33 | 1.03 | 1.07 | - | - | |
Revenue Growth (YoY) | -11.68% | 126.32% | -3.81% | - | - | - |
Gross Profit | 2.06 | 2.33 | 1.03 | 1.07 | - | - |
Selling, General & Admin | 0.62 | 1.04 | 1.61 | 3.66 | 3.8 | 0.06 |
Depreciation & Amortization Expenses | 0.35 | 0.34 | 0.3 | 0.27 | 0.07 | 0 |
Research & Development | 0.14 | 0.09 | 0.01 | 0.41 | - | - |
Other Operating Expenses | -0.04 | -0.02 | 0.11 | 0.9 | - | 0.23 |
Total Operating Expenses | 1.06 | 1.45 | 2.02 | 5.24 | 3.86 | 0.29 |
Operating Income | 0.58 | -0.03 | -1.68 | -3.08 | -3.8 | -0.29 |
Interest Income | - | - | - | - | - | 0 |
Interest Expense | -0.15 | -0.16 | -0.15 | -0.07 | -0.02 | - |
Other Non-Operating Income (Expense) | -0.61 | -0.99 | -0.19 | -5.68 | 0.01 | - |
Total Non-Operating Income (Expense) | -0.76 | -1.15 | -0.34 | -5.75 | -0 | 0 |
Pretax Income | -0.18 | -1.18 | -2.02 | -8.83 | -3.8 | -0.29 |
Net Income | -0.18 | -1.18 | -2.02 | -10.5 | -3.87 | -0.29 |
Net Income to Common | -0.18 | -1.18 | -2.02 | -10.5 | -3.87 | -0.29 |
Shares Outstanding (Basic) | 297 | 233 | 191 | 186 | 125 | 10 |
Shares Outstanding (Diluted) | 297 | 233 | 191 | 186 | 125 | 10 |
Shares Change (YoY) | 38.30% | 21.54% | 3.05% | 48.28% | 1192.18% | -80.62% |
EPS (Basic) | - | 0.01 | 0.01 | 0.06 | 0.03 | -0.03 |
EPS (Diluted) | - | 0.01 | 0.01 | 0.06 | 0.03 | -0.03 |
EPS Growth | - | - | -83.33% | 100.00% | - | - |
Shares Outstanding | 308.61 | 308.61 | 191.72 | 190.74 | 131.09 | 125.64 |
Free Cash Flow | -0.66 | -0.92 | -1.46 | -4.43 | -3.25 | -0.21 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.03 | -0.02 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | - | - |
Operating Margin | 28.16% | -1.10% | -162.81% | -287.56% | - | - |
Profit Margin | -8.83% | -50.46% | -195.80% | -824.53% | - | - |
FCF Margin | -32.20% | -39.35% | -141.50% | -413.60% | - | - |
EBITDA | 0.93 | 0.32 | -1.38 | -2.81 | -3.73 | -0.29 |
EBITDA Margin | 45.02% | 13.63% | -134.07% | -262.68% | - | - |
EBIT | 0.58 | -0.03 | -1.68 | -3.08 | -3.8 | -0.29 |
EBIT Margin | 28.16% | -1.10% | -162.81% | -287.56% | - | - |